HLF
Herbalife Ltd
$
9.160
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
9.260
Open
9.000
VWAP
9.14
Vol
2.68M
Mkt Cap
944.45M
Low
8.850
Amount
24.44M
EV/EBITDA(TTM)
3.68
Total Shares
103.11M
EV
2.75B
EV/OCF(TTM)
10.35
P/S(TTM)
0.19
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members. The Company has two geographical segments: Primary Reporting Segment (North America, Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific regions) and China. Its products are classified into five categories. The Weight Management category includes meal replacements, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism-boosting teas. The Targeted Nutrition category features functional beverages and dietary supplements. The Energy, Sports, and Fitness category consists of products that support a healthy and active lifestyle. The Outer Nutrition segment offers facial skincare, body care, and hair care products. The Literature and Promotional Items include start-up kits, sales tools, and educational materials.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
1.26B
+1.47%
0.474
-16.77%
1.24B
+2.48%
0.517
+43.69%
1.28B
+4.77%
0.603
+2.25%
Estimates Revision
The market is revising No Change the revenue expectations for Herbalife Ltd. (HLF) for FY2025, with the revenue forecasts being adjusted by -0% over the past three months. During the same period, the stock price has changed by 34.51%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+1.47%
In Past 3 Month
Stock Price
Go Up
+34.51%
In Past 3 Month
1 Analyst Rating
-1.75% Downside
Wall Street analysts forecast HLF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLF is 9.00 USD with a low forecast of 9.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
-1.75% Downside
Current: 9.160
Low
9.00
Averages
9.00
High
9.00
-1.75% Downside
Current: 9.160
Low
9.00
Averages
9.00
High
9.00
Mizuho
Neutral
maintain
$8 -> $9
2025-07-28
Reason
Mizuho
Price Target
$8 -> $9
2025-07-28
maintain
Neutral
Reason
Mizuho raised the firm's price target on Herbalife to $9 from $8 and keeps a Neutral rating on the shares. The firm adjusted targets in the food producer group ahead of the Q2 reports. Low stock valuations in the sector are attractive but are overshadowed by growth concerns, the analyst tells investors in a research note.
DA Davidson
Linda Bolton Weiser
Hold
to
Strong Buy
Upgrades
$7.5 → $14
2025-03-21
Reason
DA Davidson
Linda Bolton Weiser
Price Target
$7.5 → $14
2025-03-21
Upgrades
Hold
to
Strong Buy
Reason
DA Davidson upgraded Herbalife to Buy from Neutral with a $14 price target.
DA Davidson
Linda Bolton Weiser
Hold
Maintains
$7.5
2025-02-20
Reason
DA Davidson
Linda Bolton Weiser
Price Target
$7.5
2025-02-20
Maintains
Hold
Reason
Reports Q4 revenue $1.2B, consensus $1.19B. "With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA margins, we enter 2025 with strong momentum," said Michael Johnson, Chairman and CEO.
Mizuho
John Baumgartner
Hold
Maintains
$8 → $9
2024-11-01
Reason
Mizuho
John Baumgartner
Price Target
$8 → $9
2024-11-01
Maintains
Hold
Reason
Mizuho raised the firm's price target on Herbalife to $9 from $8 and keeps a Neutral rating on the shares. The company's Q3 adjusted EBITDA beat on benefits from savings while global volume points remained soft, the analyst tells investors in a research note.
DA Davidson
Linda Bolton Weiser
Hold
Maintains
$13 → $7.5
2024-10-31
Reason
DA Davidson
Linda Bolton Weiser
Price Target
$13 → $7.5
2024-10-31
Maintains
Hold
Reason
Reports Q3 revenue $1.20B, consensus $1.24B. The company said, "Our financial foundation is strong. Third quarter net sales were in line with our expectations, adjusted EBITDA exceeded guidance and distributor recruiting is up worldwide year-over-year. Our new business initiatives are taking root as we continue on our path to sustainable top-line growth."
B. Riley Securities
Jeff Van Sinderen
Strong Buy
Maintains
$17 → $12
2024-10-31
Reason
B. Riley Securities
Jeff Van Sinderen
Price Target
$17 → $12
2024-10-31
Maintains
Strong Buy
Reason
Reports Q3 revenue $1.20B, consensus $1.24B. The company said, "Our financial foundation is strong. Third quarter net sales were in line with our expectations, adjusted EBITDA exceeded guidance and distributor recruiting is up worldwide year-over-year. Our new business initiatives are taking root as we continue on our path to sustainable top-line growth."
See All Ratings
Valuation Metrics
The current forward P/E ratio for Herbalife Ltd (HLF.N) is 3.96, compared to its 5-year average forward P/E of 7.41. For a more detailed relative valuation and DCF analysis to assess Herbalife Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
7.41
Current PE
3.96
Overvalued PE
10.27
Undervalued PE
4.55
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
6.66
Current EV/EBITDA
4.50
Overvalued EV/EBITDA
8.17
Undervalued EV/EBITDA
5.16
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
0.47
Current PS
0.18
Overvalued PS
0.79
Undervalued PS
0.16
Financials
Annual
Quarterly
FY2025Q2
YoY :
-1.72%
1.26B
Total Revenue
FY2025Q2
YoY :
+39.34%
184.90M
Operating Profit
FY2025Q2
YoY :
+946.81%
49.20M
Net Income after Tax
FY2025Q2
YoY :
+860.00%
0.48
EPS - Diluted
FY2025Q2
YoY :
+10.57%
73.20M
Free Cash Flow
FY2025Q2
YoY :
+0.14%
78.01
Gross Profit Margin - %
FY2025Q2
YoY :
+12.26%
3.48
FCF Margin - %
FY2025Q2
YoY :
+956.76%
3.91
Net Margin - %
FY2025Q2
YoY :
+231.47%
47.40
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
23.6K
USD
Months
3-6
3
87.4K
USD
Months
6-9
1
41.3K
USD
Months
0-12
4
132.3K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
5.6M
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
1.8M
Volume
Months
6-9
2
3.5M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
23.6K
USD
Months
3-6
3
87.4K
USD
Months
6-9
1
41.3K
USD
Months
0-12
4
132.3K
USD
Months
HLF News & Events
Events Timeline
2025-07-14 (ET)
2025-07-14
12:01:01
Herbalife falls -10.2%
2025-04-30 (ET)
2025-04-30
16:17:16
Herbalife sees FY25 revenue (2.5%) to +2.5% year-over-year
2025-04-30
16:16:47
Herbalife sees Q2 revenue (3.5%) to 0.5% year over year
Sign Up For More Events
Sign Up For More Events
News
9.5
08-06NASDAQ.COMHerbalife (HLF) Q2 2025 Earnings Call Transcript
5.0
07-07NewsfilterHerbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health
8.0
07-03NASDAQ.COMNoteworthy Thursday Option Activity: HLF, ABNB, SNPS
Sign Up For More News
People Also Watch
LXU
LSB Industries Inc
7.560
USD
+3.00%
IMXI
International Money Express Inc
14.760
USD
-0.94%
CURV
Torrid Holdings Inc
2.140
USD
0.00%
ITRN
Ituran Location and Control Ltd
42.590
USD
+3.11%
BCAX
Bicara Therapeutics Inc
10.470
USD
+4.80%
LAB
Standard BioTools Inc
1.310
USD
+2.34%
RYI
Ryerson Holding Corp
22.080
USD
+4.40%
EVER
EverQuote Inc
23.510
USD
-0.17%
TK
Teekay Corp Ltd
7.510
USD
+0.94%
KIDS
OrthoPediatrics Corp
19.610
USD
+4.25%
FAQ
What is Herbalife Ltd (HLF) stock price today?
The current price of HLF is 9.16 USD — it has increased 2.81 % in the last trading day.
What is Herbalife Ltd (HLF)'s business?
What is the price predicton of HLF Stock?
What is Herbalife Ltd (HLF)'s revenue for the last quarter?
What is Herbalife Ltd (HLF)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Herbalife Ltd (HLF)'s fundamentals?
How many employees does Herbalife Ltd (HLF). have?